Posterior reversible encephalopathy syndrome in systemic lupus erythematosus

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1607-1611

  Varaprasad, Irlapati Rajendra ^a   Agrawal, Sumeet ^a   Prabu, Vadivelmurugan Nagasubramani Naga ^a   Rajasekhar, Liza ^a   Kanikannan, Meena Angamuthu ^a   Narsimulu, Gumdal ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Lupus; Lupus nephritis; Neuropsychiatric lupus; Posterior reversible encephalopathy syndrome

Indexed keywords

AMLODIPINE; CARBAMAZEPINE; CLOBAZAM; CYCLOPHOSPHAMIDE; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOSARTAN; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; OXCARBAZEPINE; PHENYTOIN; PRAZOSIN; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEMIPARESIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; NEUROLOGIC DISEASE; ONSET AGE; PATIENT CARE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RISK FACTORS; YOUNG ADULT;

EID: 79961122158     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101308     Document Type: Article

References (23)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500. (Pubitemid 26067737)
2. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. AJR Am J Roentgenol 1985;144:1027-31. (Pubitemid 15033127)
3. Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989;48:1014-22. (Pubitemid 20014805)
4. Sibbitt WL Jr, Brooks WM, Haseler LJ, Griffey RH, Frank LM, Hart BL, et al. Spin-spin relaxation of brain tissues in systemic lupus erythematosus. A method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus. Arthritis Rheum 1995;38:810-8.
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
6. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure classification of hypertension. Washington, DC: US Department of Health and Human Services. [Internet. Accessed March 10, 2011.] Available from: http://www.nhlbi.nih.gov/guidelines/hypertension/express. pdf
7. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990;2:161-92.
8. Barttynski WS. Posterior reversible encephalopathy syndrome, Part 2: Controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol 2008;29:1043-9.
9. Gottrand F, Largilliere C, Farriaux J-P. Cyclosporine neurotoxicity. N Engl J Med 1991;324:1744-5.
10. Preston GA, Yang JJ, Xiao H, Falk RJ. Understanding the pathogenesis of ANCA: where are we today? Cleve Clin J Med 69:SII51-SII54.
11. Baizabal-Carvallo JF, Barragán-Campos HM, Padilla-Aranda HJ, Alonso-Juarez M, Estañol B, Cantú-Brito C, et al. Posterior reversible encephalopathy syndrome as a complication of acute lupus activity. Clin Neurol Neurosurg 2009;111:359-63.
12. Laustrup H, Voss A, Green A, Junker P. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. Lupus 2010;19:239-46.
13. Mak A, Chan BP, Yeh IB, Ho RC, Boey ML, Feng PH, et al. Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology 2008;47:256-62. (Pubitemid 351267188)
14. Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, Combes A, Tieulié N, et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008;17:139-47. (Pubitemid 351346449)
15. Levite M, Ganor Y. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. Exp Rev Neurother 2008;8:1141-60. (Pubitemid 351962080)
16. Shibata M, Kibe T, Fujimoto S, Ishikawa T, Murakami M, Ichiki T, et al. Diffuse central nervous system lupus involving white matter, basal ganglia, thalami and brainstem. Brain Dev 1999;21:337-40. (Pubitemid 29299384)
17. Cuadrado MJ, Sanna G. Headache and systemic lupus erythematosus. Lupus 2003;12:943-6. (Pubitemid 38082091)
18. Magnano MD, Bush TM, Herrera I, Altman RD. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2006;35:396-402. (Pubitemid 43831154)
19. Johnson SR, Harvey PJ, Floras JS, Iwanochko M, Ibanez D, Gladman DD, et al. Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations. Lupus 2004;13:590-3. (Pubitemid 39145488)
20. Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002;277:29669-73.
21. Kurahashi H, Okumura A, Koide T, Ando Y, Hirata H, Magota M, et al. Posterior reversible encephalopathy syndrome in a child with bronchial asthma. Brain Dev 2006;28:544-6. (Pubitemid 44051820)
22. Bressler RB, Huston DP. Water intoxication following moderate-dose intravenous cyclophosphamide. Arch Intern Med 1985;145:548-9. (Pubitemid 15140755)
23. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.